Using advanced imaging to understand breast cancer and its treatment response
Dedicated breast PET and MRI for characterization of breast cancer and its response to therapy
This study is looking at how two special imaging techniques, dbPET and MRI, can help doctors understand breast cancer better and see how well it responds to treatment, so patients can get more accurate information about their care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10604304 on NIH RePORTER |
What this research studies
This research investigates the use of dedicated breast positron emission tomography (dbPET) and magnetic resonance imaging (MRI) to better characterize breast cancer and monitor how well it responds to neoadjuvant chemotherapy. By combining the strengths of both imaging techniques, the study aims to provide earlier insights into tumor metabolism and treatment effectiveness. The goal is to develop a user-friendly and cost-effective imaging technology that can be integrated into routine clinical practice for breast cancer treatment. Patients may benefit from more accurate assessments of their cancer's response to therapy, potentially leading to improved treatment decisions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with early-stage breast cancer who are about to undergo neoadjuvant chemotherapy.
Not a fit: Patients with advanced or metastatic breast cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment strategies for breast cancer patients.
How similar studies have performed: Previous research has shown promising results using advanced imaging techniques for cancer characterization, indicating potential for success in this novel approach.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Hylton-Watson, Nola M. — University of California, San Francisco
- Study coordinator: Hylton-Watson, Nola M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.